Peter Martin, MD
Weill Medical College of Cornell University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter Martin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:33 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02471911 · KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell LymphomaWeill Medical College of Cornell University · completed · Diffuse Large B-Cell Lymphoma · principal investigator
- Ph2NCT01779167 · Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom MacroglobulinemiaWeill Medical College of Cornell University · terminated · Waldenstrom Macroglobulinemia · principal investigator
- Ph2NCT01263899 · A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid MalignanciesS*BIO · completed · Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma · principal investigator
- Ph1/Ph2NCT01147393 · Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular LymphomaWeill Medical College of Cornell University · terminated · Follicular Lymphoma · principal investigator
- Ph1/Ph2NCT01120834 · Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)Weill Medical College of Cornell University · completed · Lymphoma · principal investigator
- Ph1/Ph2NCT01004991 · Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell LymphomaWeill Medical College of Cornell University · completed · Diffuse Large B Cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.